Cargando…
Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
Objective: This study compares 3 cohorts of patients with schizophrenia before, during, and after initiating treatment with fluphenazine decanoate (FD), haloperidol decanoate (HD), or long-acting injectable risperidone (LAR). Methods: Administrative data are analyzed from California Medicaid (Medi-C...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779880/ https://www.ncbi.nlm.nih.gov/pubmed/17470444 http://dx.doi.org/10.1093/schbul/sbm033 |